大鼠[4]共150只雄性Sprague-Dawley大鼠(年龄10-12周;体重280-320g;用于本研究。大鼠随机分为三组:假手术组(假手术组) ; n = 15); TBI组(TBI; n = 35)和TBI + Harmine治疗组(Harmine; n = 35)。在TBI(ip,30 mg/kg/d)后立即给予Harmine用于向上假性和TBI组接受等体积的0.9%生理盐水(ip)。大鼠按如下分组进行行为恢复检查:Sham,n = 3; TBI,n = 7;和Harmine,n = 7.在TBI后,在第1,3和5天评估NSS。每只大鼠由对动物治疗不知情的观察者进行评估[4]。
数据来源文献
[1]. Glennon RA, et al. Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend. 2000 Aug 1;60(2):121-32. [2]. Neumann F, et al. DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives. Sci Rep. 2018 Feb 12;8(1):2859. [3]. Zhang L, et al. Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells. Cancer Biol Ther. 2015;16(11):1585-92. [4]. Zhong Z, et al. Treatment with harmine ameliorates functional impairment and neuronal death following traumatic brain injury. Mol Med Rep. 2015 Dec;12(6):7985-91.